Alpha Teknova
TKNOAlpha Teknova, Inc. (NASDAQ: TKNO) is a United States-based company that manufactures critical reagents for the life sciences industry. Its primary business focus is the production of prepared culture media, buffers, and molecular biology reagents. These products are essential components in research, development, and production workflows, supporting applications in drug discovery, biopharmaceutical manufacturing, and clinical diagnostics. The company's product portfolio is designed to meet the stringent requirements of laboratory and bioproduction environments. Its offerings include both standard formulations and custom-configured solutions, which are utilized by pharmaceutical companies, biotechnology firms, and academic research institutions. The reagents facilitate processes across key therapeutic areas, including cell and gene therapy, vaccine development, and oncology research. As a publicly traded entity, Alpha Teknova operates cGMP-compliant manufacturing facilities to ensure product consistency and quality for its clients. The company's operations are integral to the supply chain for life sciences, providing the foundational materials necessary for scientific experimentation and therapeutic production.
TKNO · Stock Price
Historical price data
About
Alpha Teknova, Inc. (NASDAQ: TKNO) is a United States-based company that manufactures critical reagents for the life sciences industry. Its primary business focus is the production of prepared culture media, buffers, and molecular biology reagents. These products are essential components in research, development, and production workflows, supporting applications in drug discovery, biopharmaceutical manufacturing, and clinical diagnostics. The company's product portfolio is designed to meet the stringent requirements of laboratory and bioproduction environments. Its offerings include both standard formulations and custom-configured solutions, which are utilized by pharmaceutical companies, biotechnology firms, and academic research institutions. The reagents facilitate processes across key therapeutic areas, including cell and gene therapy, vaccine development, and oncology research. As a publicly traded entity, Alpha Teknova operates cGMP-compliant manufacturing facilities to ensure product consistency and quality for its clients. The company's operations are integral to the supply chain for life sciences, providing the foundational materials necessary for scientific experimentation and therapeutic production.